Stock Events

Stock Events

Viridian Therapeutics (1S1.F) Q2 2025 Earnings

6MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.08

-0.98

-0.87

-0.77

Details

Expected EPS

-0.8522887108499999

Actual EPS

-0.7669484999999999

Surprise EPS

0.09

Surprise Percent

+10.01%

Description

Viridian Therapeutics (1S1.F) has reported earnings of -0.7669484999999999 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.